Mehabe score: 5 G Factor: 7 Piotski Score: 7 The stock has a rating . The mehabe team score is reflective of its fundamental and technical merits. A rating above 8 is considered good buy. The stock has a G-Factor of 7 and Piotski score of 7.
Description
Sayaji Industries is engaged in the business of manufacture of starches, modified starches as well as other derivatives like Liquid Glucose, Dextrose Monohydrate, Dextrose Anhydrous, Sorbitol and its bye-products like Maize Oil, Maize Gluten at Kathwada, Ahmedabad.(Source : 201903 Annual Report Page No:73)Site:540728Main Symbol:SAYAJIIND
Stock trades at 260.0, above its 50dma 251.84. It also trades above its 200dma 195.99. The stock remains bullish on techicals
The 52 week high is at 308.70 and the 52week low is at 96.50
Price Chart
P/E Chart
Sales and Margin
Strengths
– has delivered good profit growth of 31.89% CAGR over last 5 years
Weakness
– The company has delivered a poor sales growth of 2.12% over past five years.
– has a low return on equity of 9.35% for last 3 years.
Competition
– The industry trades at a mean P/E of 24.5x. Jubilant Ingrevia trades at the industry’s max P/E of 183.54x. 540728 trades at a P/E of 5.95x
– Industry’s mean G-Factor is 4.0 while the mean Piotski score is 9.0. 540728 has a G-Factor of 7 and Piotski scoreof 7.
– Average 1 month return for industry is 1.5%. The max 1- month return was given by Jubilant Ingrevia: a return of 29.96 %
Quarterly Results
Sales for period ended Jun 2021 is Rs 172.7 cr compared to Rs 86.19 cr for period ended Jun 2020, a rise of 100.4%
Company reported operating profit of Rs 12.79 cr for period ended Jun 2021, operating profit margin at 7.4 %.
Operating profit was negative for the same period last year thus company has improved its margins this year
The EPS for Jun 2021 was Rs 8.24 compared to Rs 14.05 for previous quarter ended Mar 2021 and Rs -9.35 for Jun 2020
Profit & Loss Statement
Profit&Loss Comments
Company reported sales of Rs 645.0 cr for period ended TTM vis-vis sales of Rs 559.0 cr for the period ended Mar 2021, a healthy growth of 13.3%. The 3 year sales cagr stood at 0.1%.
Operating margins expanded to 10.0% for period ended TTM vis-vis 9.0% for period ended Mar 2021, expansion of 100.0 bps.
Net Profit reported at Rs 28.0 cr for period ended TTM vis-vis sales of Rs 17.0 cr for the period ended Mar 2021, rising 39.3%.
Company recorded a Net Profit CAGR of 3.8% over the last 3 years
Balance Sheet Statement
Cash Flow Statement
Cash Flow comments
CashFlow from operating activities was positive.
Sales Growth
Profit Growth Statement
Profit Growth Statement
Stock Price CAGR
Return of Equity
General Comments
– The company has improved its Return on Equity (RoE) metric. The RoE on Last Year basis was 19.0% compared to 9.0% over the last 3 Years. – The stock has given a return of 122% on a 1 Year basis vis-vis a return of 1% over the last 3 Years. – The compounded sales growth on a TTM bassis is 19% vis-vis a compounded sales growth of -2% over the last 3 Years. – The compounded profit growth on a TTM basis is 421% vis-vis a compounded profit growth of 31% over the last 3 Years.
Ratios
Shareholding Pattern
– Public shareholding has remained largely constant. The Jun 2021 public holding stood at 25.01% vis-vis 25.01% for Mar 2021
Conclusion
– has delivered good profit growth of 31.89% CAGR over last 5 years – The company has delivered a poor sales growth of 2.12% over past five years.
– has a low return on equity of 9.35% for last 3 years.
